Canada orders different version of H1N1 vaccine for pregnant women.

[mzmolly]

http://www.cbc.ca/health/story/2009/09/23/h1n1-flu-shots.html

Health authorities are also debating the proposed use of an adjuvant in the pandemic shots, which boosts the effectiveness of the vaccine so a lower dose of the active ingredient can be used.

Canada's seasonal and pandemic flu vaccine contract is with GlaxoSmithKline, which makes the vaccines at its facility in Quebec City.

GSK plans to sell H1N1 vaccine that includes 3.75 microgram doses with adjuvant — 25 per cent of the size of the doses the United States is buying from pandemic vaccine suppliers that are not using adjuvants.

The federal government has ordered 50.4 million doses of vaccine, most of which will contain an adjuvant. About 1.2 million doses have been set aside that won't include the adjvuant and are intended for pregnant women. Little research has been done on the effect the adjuvant could have on them.

Other unresolved questions include whether an adjuvant is needed at all...

Actually, this is an interesting article overall, on Canada's thoughtful approach to determining their flu vaccine policy.

[Fire_Medic_Dave]

1. The US isn't using any H1N1 vaccine with adjuvant.

[mzmolly]

2. I've heard that the H1N1 doesn't have aluminum,

but I was unaware that the vaccine is lacking adjuvants all together. If true, it's good to know. Certainly a step in the right direction.

[Why Syzygy]

4. It isn't.

There are two different formulations. MF59 hasn't been approved by the FDA. It is being used in the UK. Additionally, the nasal spray contains live virus, the injection doesn't.

[mzmolly]

6. Should have known better!

;)

[Fire_Medic_Dave]

9. The vaccine in the US doesn't have adjuvants. They are using adjuvants in other countries.

[mzmolly]

11. Do you have a link or something?

Thanks. :hi:

[Fire_Medic_Dave]

12. Here you go.

http://www.democraticunderground.com/discuss/duboard.php?az=show_mesg&forum=222&topic_id=70010&mesg_id=70010

[mzmolly]

13. Fascinating read. Apparently the US Gov is now "anti-vaccine?"

Why they sound just like the "nutters"! ;)

"the safety of the additives has not been proved..."

[Fire_Medic_Dave]

14. Erring on the side of caution or placating the anti-science crowd. Who knows which?

[mzmolly]

15. One would think if the remarks were meant to placate XYZ, a statement regarding "unproven safety"

would not enter in? One might merely note consumer confidence, without the added commentary I've pointed out.

[Fire_Medic_Dave]

16. Why mention the likely cause when the fringe is so much fun?

:dilemma: ;-)

[mzmolly]

17. The "fringe" factor is in the eye of the beholder.

And apparently the standards used to place people into fringed boxes changes, depending. ;)

[Fire_Medic_Dave]

18. Absolutely correct.

:toast:

[mzmolly]

3. After a bit if digging, I've found that some formulas may be adjuvanted?

http://www.cdc.gov/h1n1flu/vaccination/statelocal/qa.htm

Q. If vaccine is adjuvanted, how will it be formulated

A. Formulation will vary by provider. For Novartis, vaccine may be preformulated with adjuvant. For CSL, GSK and Sanofi Pasteur, mixing of vaccine and adjuvant at the site of administration will be necessary. Specific information on storage requirements and procedures for mixing vaccine and adjuvant will be provided by CDC. Medimmune vaccine will not be adjuvanted.

Though the CDC says it's "unlikely"

Q. Will vaccine be adjuvanted?

A. It is unlikely H1N1 vaccine will be adjuvanted. Definitive information will be available once clinical trial data are available.

Do you have more recent info?

[Why Syzygy]

5. To add more mystery

H1N1 did not have to be newly formulated. Curious why there was big media hype about it being a "NEW" vaccine.

***
According to reports, first WHO declared a Phase 6 alert level and the CDC followed suit declaring the H1N1 flu pandemic a public health emergency. This allowed the FDA to authorize drug companies to fast track experimental vaccines skipping over the usual required testing and clinical studies repeating the history of 1976. The irony is that it appears the drug manufacturers may have held patents on the mutated Swine H1N1 Flu vaccine before it ever began its trek across the world. For example, Novartis of Switzerland is expected to supply nearly half of the vaccines in the U.S. and applied for its Swine Flu vaccine patent 3 years ago on November 6, 2006. The United States Patent and Trademark Office (USPTO) accepted and granted the application in February 2009, just about the time the flu was beginning to spread. What a coincidence? Similarly, Baxter is producing all its H1N1 vaccine at facilities in Austria and the Czech Republic. They applied for a US Vaccine Patent Application in August, 2007 two years before the present outbreak!

http://pakobserver.net/200909/30/Articles02.asp

If someone doesn't approve of the source document, there are more from a drug company's own website and other sources.

[mzmolly]

7. If true,

that is of course, disturbing.

[Why Syzygy]

8. Have to wonder why they have lied.

http://www.inloughborough.com/news/096969/World-first%20swine-flu%20vaccine%20trial%20reveals%20one%20dose%20provides%20/'strong%20immune%20response/
World-first swine-flu vaccine trial reveals one dose provides 'strong immune response'
Posted on 03/09/09
University of Leicester

Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.

The pilot study, run by the University of Leicester and Leicester Hospitals, was trialled with 100 healthy volunteers, aged between 18 and 50.

Dr Iain Stephenson, who led the trial at the Leicester Royal Infirmary, said: The clinical trial of Novartis MF59-adjuvanted cell-based A (H1N1) vaccine indicates that the swine flu vaccine elicits a strong immune response and is well-tolerated.


http://www.astrazeneca.com/media/latest-press-releases/2009/?selectedPage=5
06 January 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
AstraZeneca

About LAIV
Each dose of LAIV is formulated to contain three live attenuated influenza virus strains, which are weakened as to not cause illness: Two Type A influenza strains (A/H1N1 and A/H3N2) and one Type B strain. The vaccine strains are selected annually by the World Health Organization (WHO) based on anticipated circulating influenza strains for the upcoming season. The vaccine is sprayed into the nose, rather than by injection as with other licensed influenza vaccines, where it induces protective immunity.

In the U.S., LAIV is marketed under the trade name FluMist® (Influenza Virus Vaccine Live, Intranasal). It was approved by the U.S. Food and Drug Administration in 2003. The vaccine included in the MAA has not been registered in the European Union and is not available outside of the United States.

[Fire_Medic_Dave]

10. What are you accusing them of lying about?

[HuckleB]

20. Where is the lie?

[Fridays Child]

19. self delete